Pharmacokinetic–Pharmacodynamic Modeling of the Effectiveness and Safety of Buprenorphine and Fentanyl in Rats

ObjectiveRespiratory depression is a serious and potentially life-threatening side-effect of opioid therapy. The objective of this investigation was to characterize the relationship between buprenorphine or fentanyl exposure and the effectiveness and safety outcome in rats.MethodsData on the time course of the antinociceptive and respiratory depressant effect were analyzed on the basis of population logistic regression PK–PD models using non-linear mixed effects modeling software (NONMEM). The pharmacokinetics of buprenorphine and fentanyl were described by a three- and two-compartment model, respectively. A logistic regression model (linear logit model) was used to characterize the relationship between drug exposure and the binary effectiveness and safety outcome.ResultsFor buprenorphine, the odds ratios (OR) were 28.5 (95% CI, 6.9–50.1) and 2.10 (95% CI, 0.71–3.49) for the antinociceptive and respiratory depressant effect, respectively. For fentanyl these odds ratios were 3.03 (95% CI, 1.87–4.21) and 2.54 (95% CI, 1.26–3.82), respectively.ConclusionThe calculated safety index (ORantinociception/ORrespiratory depression) for fentanyl of 1.20 suggests that fentanyl has a low safety margin, implicating that fentanyl needs to be titrated with caution. For buprenorphine the safety index is 13.54 suggesting that buprenorphine is a relatively safe opioid.

[1]  K. Sporer.  Buprenorphine: a primer for emergency physicians. , 2004, Annals of emergency medicine.

[2]  M. Karlsson,et al.  Estimation of dosing strategies aiming at maximizing utility or responder probability, using oxybutynin as an example drug. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  T. Gan,et al.  Risk Factors for Postoperative Nausea and Vomiting , 2006, Anesthesia and analgesia.

[4]  Y. Blanloeil,et al.  Post-operative intravenous continuous analgesia: comparison of buprenorphine, fentanyl and nalbuphine. , 1996, European journal of anaesthesiology.

[5]  C. Regnard,et al.  Severe respiratory depression and sedation with transdermal fentanyl: four case studies , 2003, Palliative medicine.

[6]  A. J. Clark.  General Pharmacology , 1937, Handbuch der Experimentellen Pharmakologie.

[7]  L B Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. , 1980, Clinical pharmacology and therapeutics.

[8]  James C. Scott,et al.  Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. , 1991, Anesthesiology.

[9]  Erik Olofsen,et al.  Mechanism-based Pharmacokinetic–Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine in Healthy Volunteers , 2006, Anesthesiology.

[10]  A. R.,et al.  Review of literature , 1969, American Potato Journal.

[11]  A. Baxter.  Respiratory depression with patient-controlled analgesia , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[12]  M. Danhof,et al.  Animal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine , 2007, Clinical pharmacokinetics.

[13]  M. Danhof,et al.  Buprenorphine induces ceiling in respiratory depression but not in analgesia. , 2006, British journal of anaesthesia.

[14]  R. Ward,et al.  Intrathecal methadone and morphine for postoperative analgesia: a comparison of the efficacy, duration, and side effects. , 1988, Anesthesiology.

[15]  T. Sacco,et al.  Balanced anestesia versus total intravenous anestesia for kidney transplantation. , 2006, Minerva anestesiologica.

[16]  M. Danhof,et al.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.

[17]  M. Danhof,et al.  Mechanism‐based PK/PD Modeling of the Respiratory Depressant Effect of Buprenorphine and Fentanyl in Healthy Volunteers , 2007, Clinical pharmacology and therapeutics.

[18]  K. Hildebrand,et al.  A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain. , 2006, Pain medicine.

[19]  B. Collett,et al.  Old dog--new (ma)trix. , 2003, British journal of anaesthesia.

[20]  M Danhof,et al.  Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: prediction of tissue-dependent efficacy in vivo. , 1999, The Journal of pharmacology and experimental therapeutics.

[21]  B. Collett,et al.  III. Old dog—new (ma)trix† , 2003 .

[22]  K. Preston,et al.  Clinical pharmacology of buprenorphine: Ceiling effects at high doses , 1994, Clinical pharmacology and therapeutics.

[23]  T. Skaer.  Transdermal opioids for cancer pain , 2006, Health and quality of life outcomes.

[24]  A. Dahan,et al.  Pharmacodynamic Effect of Morphine-6-glucuronide versus Morphine on Hypoxic and Hypercapnic Breathing in Healthy Volunteers , 2003, Anesthesiology.

[25]  D. Goldstein,et al.  Definitions of “respiratory depression” with intrathecal morphine postoperative analgesia: a review of the literature , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[26]  K. Netter,et al.  Pharmacologic analysis of drug-receptor interaction , 1994 .

[27]  J. Wildsmith,et al.  ADVERSE EFFECTS OF EXTRADURAL AND INTRATHECAL OPIATES : REPORT OF A NATIONWIDE SURVEY IN SWEDEN , 1998 .

[28]  J. Degoede,et al.  The influence of oxygen on the ventilatory response to carbon dioxide in man. , 1990, The Journal of physiology.

[29]  Manfred Morari,et al.  The Well-being Model: A New Drug Interaction Model for Positive and Negative Effects , 2006, Anesthesiology.

[30]  M. Danhof,et al.  Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. , 2005, British journal of anaesthesia.

[31]  M. Danhof,et al.  Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics , 2005, Journal of Pharmacology and Experimental Therapeutics.

[32]  C. Regnard.  Book Review: Palliative care: an Oxford core text , 2003 .

[33]  L. Sheiner,et al.  THE UTILITY FUNCTION OF ANTIHYPERTENSIVE THERAPY * , 1978, Annals of the New York Academy of Sciences.

[34]  Terrence P. Kenakin,et al.  A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .

[35]  Mats O Karlsson,et al.  Pharmacokinetics of Ximelagatran and Relationship to Clinical Response in Acute Deep Vein Thrombosis , 2005, Clinical pharmacology and therapeutics.

[36]  A. Woodhouse,et al.  The Minimum Effective Concentration of Opioids: A Revisitation With Patient Controlled Analgesia Fentanyl , 1999, Regional Anesthesia & Pain Medicine.

[37]  Gordon Graham,et al.  Determination of an Optimal Dosage Regimen Using a Bayesian Decision Analysis of Efficacy and Adverse Effect Data , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[38]  M. Danhof,et al.  Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory-Depressant Effect of Buprenorphine and Fentanyl in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[39]  L. Brady,et al.  Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats. , 1982, The Journal of pharmacology and experimental therapeutics.

[40]  D J Crouch,et al.  Effects of intrathecal morphine on the ventilatory response to hypoxia. , 2000, The New England journal of medicine.

[41]  M. Danhof,et al.  Selectivity of action of 8‐alkylamino analogues of N6‐cyclopentyladenosine in vivo: haemodynamic versus anti‐lipolytic responses in rats , 1998, British journal of pharmacology.

[42]  A Cowan,et al.  Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. , 2001, The Journal of pharmacology and experimental therapeutics.

[43]  T. A. Bowdle,et al.  Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. , 1998, Drug safety.

[44]  D. Mould,et al.  Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer: a gynaecological oncology group study. , 2006, British journal of clinical pharmacology.

[45]  H. Bunting,et al.  Postoperative Analgesia After Co-administration of Clonidine and Morphine by the Intrathecal Route in Patients Undergoing Hip Replacement , 1995, Anesthesia and analgesia.